Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4477-4487

  Perez Martin, Eva ^a,b   Weiss, Marcelo ^a,b   Segundo, Fayna Diaz San ^a,b   Pacheco, Juan M ^a   Arzt, Jonathan ^a   Grubman, Marvin J ^a,b   de los Santos, Teresa ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON; INTERFERON LAMBDA 3; UNCLASSIFIED DRUG;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD ANALYSIS; CATTLE; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; EMBRYO; FOOT AND MOUTH DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; INOCULATION; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; NOSE SMEAR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; VIREMIA; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CATTLE; CATTLE DISEASES; CELL LINE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; TREATMENT OUTCOME;

ANIMALIA; BOS; BOVINAE; FOOT-AND-MOUTH DISEASE VIRUS; HUMAN ADENOVIRUS TYPE 5; SUIDAE;

EID: 84861366979     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06683-11     Document Type: Article

References (54)

1. Alexandersen S, Zhang Z, Donaldson AI, Garland AJ. 2003. The pathogenesis and diagnosis of foot-and-mouth disease. J. Comp. Pathol. 129:1-36.
2. Ank N, et al. 2008. An important role for type III interferon (IFN-lambda/ IL-28) in TLR-induced antiviral activity. J. Immunol. 180:2474-2485.
3. Ank N, et al. 2006. Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509.
4. Arzt J, Pacheco JM, Rodriguez LL. 2010. The early pathogenesis of foot-andmouth disease in cattle after aerosol inoculation. Identification of the nasopharynx as the primary site of infection. Vet. Pathol. 47:1048-1063.
5. Bautista EM, Ferman GS, Golde WT. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 92:61-73.
6. Callahan JD, et al. 2002. Use of a portable real-time reverse transcriptasepolymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. J. Am. Vet. Med. Assoc. 220:1636-1642.
7. Chinsangaram J, Koster M, Grubman MJ. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75: 5498-5503.
8. Chinsangaram J, Moraes MP, Koster M, Grubman MJ. 2003. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77:1621-1625.
9. Chinsangaram J, Piccone ME, Grubman MJ. 1999. Ability of foot-andmouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
10. Dai CY, et al. 2010. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients. Antiviral Res. 85:396-402.
11. Dias CC, Moraes MP, Diaz-San Segundo F, de los Santos T, Grubman MJ. 2011. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J. Interferon Cytokine Res. 31:227-236.
12. Diaz-San Segundo F, Moraes MP, de los Santos T, Dias CC, Grubman MJ. 2010. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. J. Virol. 84: 2063-2077.
13. Diaz-San Segundo F, et al. 2006. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J. Virol. 80:2369-2379.
14. Diaz-San Segundo F, et al. 2011. Antiviral activity of bovine type III interferon against foot-and-mouth disease virus. Virology 413:283-292.
15. Doel TR. 2003. FMD vaccines. Virus Res. 91:81-99.
16. Domingo E, et al. 2003. Evolution of foot-and-mouth disease virus. Virus Res. 91:47-63.
17. Fray MD, Mann GE, Charleston B. 2001. Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon. J. Immunol. Methods 249:235-244.
18. Grubman MJ, Baxt B. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
19. Grubman MJ, et al. 2010. Adenovirus serotype 5-vectored foot-andmouth disease subunit vaccines: the first decade. Future Virol. 5:51-64.
20. Henderson WM. 1952. A comparison of different routes of inoculation of cattle for detection of the virus of foot-and-mouth disease. J. Hyg. (Lond.) 50:182-194.
21. Hou W, et al. 2009. Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J. Virol. 83:3834-3842.
22. Iversen MB, Ank N, Melchjorsen J, Paludan SR. 2010. Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-κB than type I IFNs. J. Virol. 84:4579-4586.
23. Iversen MB, Paludan SR. 2010. Mechanisms of type III interferon expression. J. Interferon Cytokine Res. 30:573-578.
24. Jewell NA, et al. 2010. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 84:11515-11522.
25. Karpala AJ, et al. 2008. Molecular cloning, expression, and characterization of chicken IFN-lambda. J. Interferon Cytokine Res. 28:341-350.
26. Kotenko SV, et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
27. Maddur MS, Gajendragad MR, Gopalakrishna S, Singh N. 2008. Comparative study of experimental foot-and-mouth disease in cattle (Bos indicus) and buffaloes (Bubalis bubalus). Vet. Res. Commun. 32:481-489.
28. Mayr GA, O'Donnell V, Chinsangaram J, Mason PW, Grubman MJ. 2001. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152-2162.
29. Moraes MP, Chinsangaram J, Brum MC, Grubman MJ. 2003. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268-279.
30. Mordstein M, et al. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84:5670-5677.
31. Nfon CK, Ferman GS, Toka FN, Gregg DA, Golde WT. 2008. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol. 21:68-77.
32. Nfon CK, Toka FN, Kenney M, Pacheco JM, Golde WT. 2010. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunol. 23:29-41.
33. Okabayashi T, et al. 2011. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res. 160:360-366.
34. Pacheco JM, Arzt J, Rodriguez LL. 2010. Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet. J. 183:46-53.
35. Pott J, et al. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. U. S. A. 108:7944-7949.
36. Prato Murphy ML, Forsyth MA, Belsham GJ, Salt JS. 1999. Localization of foot-and-mouth disease virus RNA by in situ hybridization within bovine tissues. Virus Res. 62:67-76.
37. Reid E, et al. 2011. Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo. J. Virol. 85:4297-4308.
38. Robek MD, Boyd BS, Chisari FV. 2005. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol. 79:3851-3854.
39. Rodriguez LL, Grubman MJ. 2009. Foot and mouth disease virus vaccines. Vaccine 27(Suppl. 4):D90-D94.
40. Ryan E, Horsington J, Brownlie J, Zhang Z. 2008. Foot-and-mouth disease virus infection in fetal lambs: tissue tropism and cytokine response. J. Comp. Pathol. 138:108-120.
41. Sang Y, Rowland RR, Blecha F. 2010. Molecular characterization and antiviral analyses of porcine type III interferons. J. Interferon Cytokine Res. 30:801-807.
42. Sheppard P, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
43. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog. 4:e1000017.
44. Sutmoller P, Gaggero A. 1965. Foot-and mouth diseases carriers. Vet. Rec. 77:968-969.
45. Swaney LM. 1988. A continuous bovine kidney cell line for routine assays of foot-and-mouth disease virus. Vet. Microbiol. 18:1-14.
46. Wang J, et al. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J. Immunol. 182:1296-1304.
47. Witte K, et al. 2009. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 10:702-714.
48. Witte K, Witte E, Sabat R, Wolk K. 2010. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev. 21:237-251.
49. World Organisation for Animal Health. 2011. Manual of diagnostic testsand vaccines for terrestrial animals, chapter 2.1.5. World Organisation for Animal Health, Paris, France. http://www.oie.int/en/international-standard-setting/terrestrial-manual/access-online/
50. Wu Q, Brum MC, Caron L, Koster M, Grubman MJ. 2003. Adenovirusmediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J. Interferon Cytokine Res. 23:359-368.
51. Zhang Z, Ahmed R, Paton D, Bashiruddin JB. 2009. Cytokine mRNA responses in bovine epithelia during foot-and-mouth disease virus infection. Vet. J. 179:85-91.
52. Zhou P, et al. 2011. Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. J. Immunol. 186:3138-3147.
53. Zhou Z, et al. 2007. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J. Virol. 81:7749-7758.
54. Zhu J, Weiss M, Grubman MJ, de los Santos T. 2010. Differential gene expression in bovine cells infected with wild type and leaderless foot-andmouth disease virus. Virology 404:32-40.